PAHC logo

PAHC Phibro Animal Health Corporation

NASDAQ Global Market · Drug Manufacturers - Specialty & Generic · Healthcare

$33.29
-0.79 (-2.32%)

Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Produ…

Market Cap: $1.35Bwww.pahc.com

Price

No data yet.

Social Signal Score

55
5d
—
30d
57
3 mentions
—
60d
54
5 mentions
—
90d
53
12 mentions
—
news: 12

Analyst Ratings

14 analysts
Buyconsensus
Strong Buy 0Buy 6Hold 4Sell 4Strong Sell 0
Avg price target$49+47.2%
Low $49Median $49High $49
Current Consensus

Revenue

$386.77M+101.87%
$185.88M$256.17M$326.46M$396.75M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$2.03
$2.01–$2.05
4 analysts
FY2026
$3.07+51% YoY
$3.03–$3.10
3 analysts
FY2027
$3.48+13% YoY
$3.47–$3.50
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Daniel Bendheim
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,605
Beta
0.42
Country
US
Piotroski score
7 / 9 (Strong)
Altman Z-score
3.02
www.pahc.com